Benjamin J. Zeskind, PRESIDENT AND CEO at Immuneering Corp (IMRX), bought 21,000 shares at $2.39 ($50K) on 2025-06-18, disclosed to the SEC on 2025-06-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| IMRX | BUY | 2024-03-19 | $55K | — | Filing → |
| IMRX | BUY | 2022-03-24 | $24K | — | Filing → |
| IMRX | BUY | 2021-09-14 | $48K | — | Filing → |